Hrt Financial LP Iveric Bio, Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$9.4 - $18.59 $615,521 - $1.22 Million
65,481 New
65,481 $1.17 Million
Q1 2022

May 16, 2022
SELL
$12.15 - $16.83 $1.78 Million - $2.46 Million
-146,419 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$13.83 - $18.78 $2.02 Million - $2.75 Million
146,419 New
146,419 $2.45 Million
Q2 2021

Aug 16, 2021
SELL
$5.69 - $7.17 $67,210 - $84,692
-11,812 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$5.08 - $6.89 $60,004 - $81,384
11,812 New
11,812 $72,000

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email